Market revenue in 2023 | USD 3,267.1 million |
Market revenue in 2030 | USD 10,820.4 million |
Growth rate | 18.7% (CAGR from 2023 to 2030) |
Largest segment | Injectables |
Fastest growing segment | Injectables |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Injectables, Skin Rejuvenation |
Key market players worldwide | Hologic Inc, AbbVie Inc, Galderma Group AG Registered Shares, Alma Lasers Ltd, UltraShape Ltd. (Syneron Medical), Johnson & Johnson, Merz Pharma, Lumenis, Bausch Health Companies Inc, Cutera Inc, Revance Therapeutics Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-invasive aesthetic treatment market will help companies and investors design strategic landscapes.
Injectables was the largest segment with a revenue share of 63.38% in 2023. Horizon Databook has segmented the Japan non-invasive aesthetic treatment market based on injectables, skin rejuvenation covering the revenue growth of each sub-segment from 2018 to 2030.
Japan is the second largest market for aesthetic products and procedures in APAC countries and largest market in the world. Facial features are extremely important to the Japanese population; according to the Japan Society of Aesthetic Plastic Surgery, in 2018, approximately 90% of nearly 237,000 cosmetic surgeries performed in the country were related to the face.
In 2020, 835,556 non-invasive aesthetic treatments were carried out in the country, with hair removal, botulinum injections, chemical peels, HA injectable, and non-surgical fat reduction being the top five noninvasive procedures.
As Japanese are barely allowed long holidays, they prefer minimally invasive procedures such as fat injections, dermal & lip fillers, laser skin resurfacing, and Botox as the recovery time is quick with a low risk of side effects. Moreover, the country ranks fourth in terms of total injectable procedures (337,579) being performed globally.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan non-invasive aesthetic treatment market , including forecasts for subscribers. This country databook contains high-level insights into Japan non-invasive aesthetic treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account